3,506 reports of this reaction
1.3% of all HYDROMORPHONE HYDROCHLORIDE reports
#10 most reported adverse reaction
FATIGUE is the #10 most commonly reported adverse reaction for HYDROMORPHONE HYDROCHLORIDE, manufactured by Fresenius Kabi USA, LLC. There are 3,506 FDA adverse event reports linking HYDROMORPHONE HYDROCHLORIDE to FATIGUE. This represents approximately 1.3% of all 268,941 adverse event reports for this drug.
Patients taking HYDROMORPHONE HYDROCHLORIDE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for HYDROMORPHONE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for HYDROMORPHONE HYDROCHLORIDE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 3,506 FDA reports for HYDROMORPHONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.3% of all adverse event reports for HYDROMORPHONE HYDROCHLORIDE, making it a notable side effect.
If you experience fatigue while taking HYDROMORPHONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.